Lactone-to-Lactam Editing Alters the Pharmacology of Bilobalide
Jul 16, 2024·,,,,,,,,,,,,,,,,,,,,·
0 min read
Xiaoding Jiang
Xu He
Jonathan Wong
Stephan Scheeff
Sam Chun Kit Hau
Tak Hin Wong
Yao Qin
Chi Hang Fan
Bowen Ma
Ngai Lam Chung
Junzhe Huang
Jiajia Zhao
Yu Yan
Min Xiao
Xueqin Song
Tony K. C. Hui
Zhong Zuo
William Ka-Kei Wu
Ho Ko
Kim Hei-Man Chow
Billy Wai-Lung Ng
Abstract
Precise transformations of natural products (NPs) can fine-tune their physicochemical properties while preserving inherently complex and evolutionarily optimized parent scaffolds. Here, we report an unprecedented lactone-to-lactam transformation on bilobalide, thus improving its stability and paving the way for biological exploration of previously inaccessible chemical space that is highly representative of the parent structure. This late-stage molecular editing of bilobalide enables facile access to a unique library of lactam analogues with altered pharmacology. Through phenotypic screening, we identify BB10 as a hit compound with unexpected inhibition of ferroptotic cell death. We further reveal that BB10 suppresses ferroptosis by restoring the expression of glutathione peroxidase 4 (GPX4) in brain cells. This study highlights that even subtle changes on NP scaffolds can confer new pharmacological properties, inspiring the exploration of simple yet critical transformations on complex NPs.
Type
Publication
JACS Au 2024